AGP Executive Report
Last update: 4 hours agoRespiratory Research: Macau University of Science and Technology (MUST) launched its Respiratory Disease AI Laboratory consultancy meeting, adding eight international committee members chaired by Dr. Zhong Nanshan and signing cooperation under the China-Portugal TREMAC framework with partners including China Telecom and local hospitals. Mosquito Control Push: The Health Bureau (SSM) is stepping up inspections and mosquito control as dengue and chikungunya risks rise in summer travel, with intensified checks at high-risk sites like vacant land and construction areas. Infectious Disease Watch: SSM reported 2,755 notifiable cases in June, led by influenza (2,154), while enterovirus infections surged month-on-month and norovirus and scarlet fever also climbed. Heat Safety Alerts: Macau issued a Yellow hot weather alert as temperatures may hit 33°C+, with the Health Bureau urging residents to watch for heat syncope, cramps, exhaustion and heatstroke and to use the heat shelter when alerts are active. Anti-Smoking Law Update: The Legislative Assembly passed tougher anti-smoking rules, including new outdoor no-smoking zones and a ban on e-cigarettes in public spaces, with designated areas starting from a first batch via executive order. Oncology & Rare Disease News (Regional): GSK’s Nuvalent deal is paying off as the FDA approves its ROS1 lung cancer drug Jideytro, while China approved Haisco’s sipupopan succinate for a rare blood disorder. Care for Seniors: SSM and IAS say a citywide assessment found over 1,500 seniors with unusual emotional symptoms, and they’re expanding community support plus self-check links via the Macao One Account platform. Partnership for Oncology Supportive Care: Menarini Asia-Pacific partnered with Pharmacosmos to register and distribute Cosela® (trilaciclib) across Asia-Pacific, including Hong Kong/Macau.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.